Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Sunovion seeks FDA approval for COPD treatment

By , Globe Staff

The Marlborough company reported positive test results in a clinical trial that enrolled 653 patients with COPD at 45 sites across the United States.

Seres Therapeutics stock plunges on disappointing drug trial results

By , Globe Staff

The Cambridge biotech company said a mid-stage trial of its experimental drug to treat clostridium difficile failed to meet its primary goal.

Vertex’s cystic fibrosis drug on track to top $1 billion in sales this year

By , Globe Staff

Vertex Pharmaceuticals Inc. said Wednesday that its cystic fibrosis drug Orkambi remains on track to generate sales of at least $1 billion this year.

Bankruptcy court approves $40 million takeover of Bind Therapeutics

By , Globe Staff

Pfizer will buy the Cambridge-based cancer drug developer, which ran into financial trouble earlier this year.